Elizabeth Buck is CHIEF SCIENTIFIC OFFICER of Black Diamond Therapeutics, Inc.. Currently has a direct ownership of 170,192 shares of BDTX, which is worth approximately $388,037. The most recent transaction as insider was on Jan 30, 2025, when has been sold 75,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 170K
n/a 3M change
n/a 12M change
Total Value Held $388,037

Elizabeth Buck Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 30 2025
BUY
Grant, award, or other acquisition
-
75,000 Added 30.59%
170,192 Common Stock
EB

Elizabeth Buck

CHIEF SCIENTIFIC OFFICER
Cambridge, MA

Track Institutional and Insider Activities on BDTX

Follow Black Diamond Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BDTX shares.

Notify only if

Insider Trading

Get notified when an Black Diamond Therapeutics, Inc. insider buys or sells BDTX shares.

Notify only if

News

Receive news related to Black Diamond Therapeutics, Inc.

Track Activities on BDTX